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ABSTRACT
Introduction: Extramedullary plasmacytomas are present in 13% of multiple myeloma (MM) patients. Less than 5% of MM cases are non-
secretory. The orbital location is uncommon and a minority of orbital tumours are plasmacytomas.
Description: The patient was a 71-year-old man, with right proptosis, retro-ocular pain and epistaxis with visual acuity 2/10, limitation of upper 
eye movement and scattered ecchymosis. Blood tests revealed severe anaemia, coagulopathy, increased serum creatinine, LDH and C-RP 
without improvement after antimicrobial treatment. Peripheral immunophenotyping showed 9.4% of plasma cells with intracytoplasmic 
clonal κ chains. IgG and λ chains were decreased with normal plasma and urine immunofixation. Orbital CT: retro-orbital superomedial 
tumour with bone destruction. Histology of the tumour and bone biopsy was consistent with plasmacytoma. The patient was deceased in 2 
weeks.
Discussion: MM accounts for 10% of haematopoietic tumours; 7% of cases present with plasmacytomas at diagnosis. Orbital locations are 
rarely reported (frequently in the temporal region). Proptosis, ptosis and reduced visual acuity are common symptoms. However, orbital 
pain is less frequent. Most cases of MM demonstrate hypergammaglobulinaemia. Only 5% of MM cases are non-secretory.
The uncommon location, topography, symptom peculiarities and absence of monoclonality led to the diagnostic challenge of this fatal case 
of MM.
LEARNING POINTS
• Multiple myeloma (MM) represents 10% of malignant haematologic disease, 13% of which presents plasmacytomas (mostly in the axial 
skeleton).
• Orbital plasmacytoma is an uncommon presentation of MM and only 1% of orbital tumours are plasmacytomas. Proptosis is the most 
common symptom.
• Although the majority of MM cases demonstrate hypergammaglobulinaemia, non-secretory MM is described as constituting less than 
5% of cases.
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CASE DESCRIPTION
A 71-year-old man presented to the emergency department with right progressive proptosis, retro-ocular and headache pain, reduced 
visual acuity, and epistaxis over the previous 4–6 weeks, with healthcare status deterioration in the previous 2 weeks. He denied fever, 
diplopia, ocular trauma or weight loss. He had a Gleason 6 prostatic tumour (diagnosed 2 months previously), glaucoma and ankylosing 
spondylitis (diagnosed 10 years previously) medicated with prednisolone and salazopyrin. There was no other personal or family history 
of thyroid or malignant diseases. The ophthalmologic examination revealed conjunctival exudate and hyperaemia (without cellulitis), and 
exuberant proptosis with inferior and temporal dystonia and overdraft limitation. Visual acuity of the right eye was 2/10. Biomicroscopy 
revealed right ocular nummular keratitis with a normal anterior chamber and left ocular aphakia. The ocular fundus did not show optic 
nerve compression, macular alterations or papilloedema. Bilateral intraocular tension was normal. The patient had no fever; however, he 
was hypotensive, tachycardic, with active epistaxis and scattered ecchymosis. He had no palpable thyroid and the thoracic and abdominal 
examinations were normal, without adenopathies.
Methods and Procedures
After multidisciplinary discussion and orbital computerized tomography (CT) suspicion of sinusitis with periorbital abscess, broad-spectrum 
antimicrobial and liposomal amphotericin B therapy was initiated and the patient was admitted to the intensive care unit. Orbital CT (Fig. 
1) revealed an extraconic, with a peripheral cotton wool-like appearance, retro-orbital and superomedial tumour (2.2 cm), with frontal 
and ethmoidal bone (right orbital lamina) destruction, mass effect on the superior rectus muscle, exuberant filling of the ethmoidal sinus, 
reactive osteitis and nasal polyposis, without intracranial invasion.
Figure 1. The arrow shows the posterior orbital tumour (superior and medial in the orbit), with mass effect on the superior rectus muscle. 3D reconstruction reveals frontal 
and orbital lamina destruction 
Blood tests disclosed severe normocytic, normochromic anaemia (the lowest value was 4.0 g/dl), severe thrombocytopenia (the lowest value 
was 21 G/l), increased aPTT and PT (prothrombin 27%), acute kidney injury (KDIGO stage 2) with metabolic acidosis and hyperkalaemia (6.5 
mmol/l), reduced albumin (2.7 g/dl), elevated C-RP (15 mg/dl, normal <0.5), LDH (1,631 U/l, reference 125–220) and uric acid (13.3 mg/dl, 
reference 3.5–7.2). Calcium and the ESR were normal. Blood flow cytometry with immunophenotyping showed 9.4% of plasma cells with 
intracytoplasmic clonal κ chains. Immunoglobulin (Ig) G and λ chains were decreased with a normal κ/λ ratio, IgM and IgA. β2-microglobulin 
was increased: 13.8 mg/l (1.09–2.53). Plasma and urine immunofixation was normal. Blood, urine and respiratory cultures were negative. 
Supraciliary orbitotomy with biopsy of the tumour (Fig. 2) was performed, revealing a friable subperiosteum tumour with invasion of the 
frontal sinus; histological examination unveiled CD138+ plasma cells, consistent with plasmacytoma.
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Bone biopsy (Fig. 3) confirmed multiple myeloma (MM) with extensive fibrosis, residual haematopoiesis and κ light chain focal expression. 
Figure 2. Orbital tumour biopsy: (A) 
CD138+ mature plasma cells: 10 × 20, 
with (B) pronounced pleomorphism, 
H&E: 10 × 40. Image provided by Maria 
José Julião (PhD) 
Figure 3. Bone marrow biopsy: multiple 
myeloma – (A) MUM-1 cells, CD3, 
CD20 and cytokeratins were negative. 
Extensive fibrosis with residual 
haematopoiesis and (B) κ light chain 
focal expression (λ light chain negative): 
10 × 40. Image provided by Raquel Seiça 
(PhD)
Due to the patient’s status, therapy with dexamethasone and cyclophosphamide was proposed but he was deceased a few days after 
admission.
DISCUSSION
MM represents 10% of all haematologic malignant neoplasms, with peak incidence between the fifth and eighth decades of life, without 
sex preference[2]. In the report from Varettoni et al. looking at 1,003 cases[1], extramedullary disease occurred in 13% of cases, and 7% 
(approximately half) presented with plasmacytoma at the time of diagnosis, mostly in the axial region. When considering head locations only, 
80% occurred in the upper respiratory tract and oral cavity. Orbital involvement is uncommon and in more than half of cases it is only discovered 
after MM diagnosis[2]. Moreover, in a review of 2,480 cases[3], most orbital tumours were benign; 317 (13%) were lymphoproliferative lesions 
but only 1% of them were plasmacytomas. These authors even presented a patient with an atypical plasmacytoma location, without previous 
haematologic neoplasm, which initially simulated sinusitis with subperiosteum abscess. 
Proptosis is the most common (81%) symptom[1], with ptosis, reduced visual acuity, oedema and diplopia also being frequently reported[2]. 
However, ocular pain is rarely described. 
Most orbital tumours are superior and laterally located, 90% extraconic. The tumour medial extension and knowledge that most cases 
report bone destruction[3] explains the patient’s epistaxis. 
This case presented decreased immunoglobulins and normal plasma and urine immunofixation, reported in less than 15% of cases, although 
most MM cases demonstrate hypergammaglobulinaemia, mostly IgG[2].
The authors report a rare case of an inaugural MM that presented as an atypical orbital plasmacytoma, the uncommon topography, symptom 
particularities and monoclonality absence of which led to a challenging diagnosis of an advanced and fatal malignant tumour: MM.
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